Please assess the completion status of the following clinical trial:

Trial Title: Blood-brain Barrier Permeability Study in Adults With Meningitis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* patients over 18 years old~* diagnosed with meningitis in the examination of cerebrospinal fluid~Exclusion Criteria:~* allergic to any of the contrast agents~* a lack of consent to the test~* liver failure and kidney failure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- ICG washout kinetics assessment (Type: EXPERIMENTAL): Intravenous administration of 5-10 mg indocyanine green (ICG-PULSION), once per subject
- Pulse oximeter monitor (Type: OTHER): Monitoring of a person's oxygen saturation (SO2), peripheral oxygen saturation
- Gadolinium washout kinetics assessment (Type: EXPERIMENTAL): 20 mL of gadolinium (Gadovist, Bayer, Germany) injection at 5 mL/s, once per subject

Based on this trial design, predict the completion outcome and termination type (if applicable).